+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharmaceutical Contract Research Services Market by Scale of Operation, Target Therapeutic Areas and Key Geographies and Rest of the World): Industry Trends and Global Forecasts, 2021-2030

  • PDF Icon

    Report

  • 503 Pages
  • June 2021
  • Region: Global
  • Roots Analysis
  • ID: 5441018
Description Jump to:

Overview

Small molecule drugs account for nearly 90% of the contemporary therapeutics pipeline. In 2020, the US FDA’s Center for Drug Evaluation and Research approved 35 small molecule drugs, representing 66% of the total number of new molecular entities (NMEs) clearing regulatory review in the same year. It is worth highlighting that the process of drug development, beginning from the discovery of a pharmacological lead to the commercialization of a clinically validated product, takes around 10-15 years. Moreover, drug discovery and clinical research are capital intensive processes, which, on average, require investments in the range of USD 4-10 billion. Further, it is a well-known fact that only a small proportion of lead molecules that are shortlisted for further investigation during the discovery phase, actually make it into the clinical phase, and an even lesser number of product candidates enter the market. Therefore, to optimize on internal resource utilization and save costs, innovator companies in the pharmaceutical industry are increasingly outsourcing various aspects of their discovery-stage operations to specialty contract research organizations (CROs). 

Modern CROs offer a plethora of pharmaceutical discovery (such as target discovery & validation, hit identification (using strategies such as high-throughput screening, fragment-based screening, virtual screening, knowledge-based screening and DNA-encoded libraries), and lead generation / optimization) and product development related services, leveraging a variety of advanced technologies to cater to the evolving needs of sponsors / clients. As indicated earlier, engaging third party service providers offers both time and cost related benefits to drug / therapy developers. Currently, over 500 companies / organization claim to be actively providing contract research services for small molecule drugs. In the recent past, many of the service providers in this domain forged strategic alliances and / or acquired other players, in order to further enhance their respective service portfolios and thereby, consolidate their presence in the industry. The aforementioned developments may be attributed to the growing preference for one-stop-shops among sponsor companies, and the gradual acceptance of outsourcing as a viable and beneficial operating model. Based on prevalent trends and projections of how the pharmaceutical pipeline is likely to evolve over the coming years, we believe that demand for pharmaceutical CROs is going to grow at a steady pace. Consequently, the small molecule drug discovery and development services market is anticipated to witness consistent growth till 2030.


Scope of the Report

The "Pharmaceutical Contract Research Services Market, 2021-2030" report features an extensive study on contract service providers engaged in discovery, preclinical and clinical research of small molecule drugs. The study features in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field.


Amongst other elements, the report includes:

  • A detailed review of the overall landscape of the pharmaceutical services market, highlighting the contributions of CROs, along with information on their year of establishment, company size, scale of operation (discovery, preclinical and clinical), location of headquarters, type(s) of services offered (target discovery & validation, hit identification, hit-to-lead & lead generation, lead optimization, bioanalytical studies, other preclinical services, clinical trials related services, consulting and regulatory affairs management), hit identification strategy used (high-throughput screening, fragment based screening, virtual screening (structure based virtual screening, ligand based virtual screening and unspecified virtual screening), knowledge based screening, DNA Encoded Library (DEL) based screening and others), type of business model (fee-for-service and full time equivalent) and target therapeutic area. 
  • Elaborate profiles of prominent CROs engaged in offering pharmaceutical related services. Each company profile features a brief overview of the company, its financial information (if available), service portfolio and recent developments and an informed future outlook.
  • An insightful competitiveness analysis, highlighting prominent pharmaceutical contract service providers based on supplier strength (considering a company's years of experience), and service strength (which takes into account the service offerings, scale of operation, hit identification strategies and subject specific agreements).
  • An analysis of the recent collaborations (signed since 2018) focused on the CROs offering pharmaceutical related services, based on various parameters, such as year of agreement, type of agreement, scale of operation and target therapeutic area.
  • A detailed analysis of the various mergers and acquisitions that have taken place in this domain, during the period 2018-2021. It is worth mentioning that the data captured during our research was analyzed based on multiple parameters, such as year, type of acquisition and geographical location of the companies.
  • A region-wise, detailed analysis of the total cost of ownership for a pharmaceutical contract research service provider. It features an informed estimate of direct and indirect expenses taking into consideration close to 100 relevant parameters over a span of 20 years.
  • A case study on the current market landscape of biopharmaceutical contract research service providers, including information on the year of establishment, company size, scale of operation and type of services offered.

One of the key objectives of this report was to evaluate the current opportunity and the future potential of the pharmaceutical CROs market over the coming decade. We have provided an informed estimate on the likely evolution of the market in the short to mid-term and long term, for the period 2021-2030. The report also features the likely distribution of the current and forecasted opportunity across [A] scale of operation (discovery services, preclinical services and clinical stage services), [B] target therapeutic area (cardiovascular disorder, dermatological disorders, infectious disorder, inflammatory disorder, neurological disorder, oncological disorder, ophthalmological disorder, respiratory disorder and other disorders) and [C] key geographical region (North America, Europe, Asia-Pacific, Latin America, MENA (Middle East and North Africa) and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry's growth. The opinions and insights presented in the report were also influenced by discussions held with senior stakeholders in the industry.

All actual figures have been sourced and analyzed from publicly available information forums and inputs from primary research. Financial figures mentioned in this report are in USD, unless otherwise specified.


Key Questions Answered

  • Who are the leading players offering contract research services for small molecules?
  • Which partnership models are commonly adopted by stakeholders engaged in this industry?
  • What are the key value drivers of the merger and acquisition activity observed within this domain?
  • What are the likely future trends in contract research services market?
  • How is the current and future opportunity likely to be distributed across key market segments?
  • What is the total cost of ownership required to set up a pharmaceutical contract research organization?

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Drug Development
3.3. Drug Discovery Process
3.3.1. Target Identification
3.3.2. Target Discovery and Validation
3.3.3. Hit Generation
3.3.3.1. High-Throughput Screening
3.3.3.2. Fragment-based Screening
3.3.3.3. Virtual Screening
3.3.3.4. DNA-Encoded Libraries Screening
3.3.4. Hit-to-Lead and Lead Generation
3.3.5. Lead Optimization
3.4. Challenges Associated with Small Molecule Discovery
3.5. Need for Outsourcing Drug Discovery Operations
3.6 Guidelines for Selecting a Contract Research Service Provider
3.7. Concluding Remarks

4. PHARMACEUTICAL CONTRACT RESEARCH SERVICE PROVIDERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Pharmaceutical Contract Research Service Providers: List of Industry Players
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Scale of Operation
4.2.4. Analysis by Location of Headquarters
4.2.5. Analysis by Company Size and Scale of Operation
4.2.6. Analysis by Types of Services Offered
4.2.7. Analysis by Location of Headquarters and Types of Services Offered
4.2.8. Analysis by Hit Identification Strategy Used
4.2.9. Analysis by Type of Business Model
4.2.10. Analysis by Target Therapeutic Area

5. COMPANY PROFILES
5.1. Chapter Overview
5.2. Pharmaceutical Contract Research Service Providers in North America
5.2.1. Albany Molecular Research (AMRI)
5.2.1.1. Company Overview
5.2.1.2. Financial Information
5.2.1.3. Service Portfolio
5.2.1.4. Recent Developments and Future Outlook
5.2.2. BioDuro
5.2.2.1. Company Overview
5.2.2.2. Service Portfolio
5.2.2.3. Recent Developments and Future Outlook
5.2.3. BOC Sciences
5.2.3.1. Company Overview
5.2.3.2. Service Portfolio
5.2.3.3. Recent Developments and Future Outlook
5.2.4. Catalent Pharma
5.2.4.1. Company Overview
5.2.4.2. Financial Information
5.2.4.3. Service Portfolio
5.2.4.4. Recent Developments and Future Outlook
5.2.5. Charles River Laboratories
5.2.5.1. Company Overview
5.2.5.2. Financial Information
5.2.5.3. Service Portfolio
5.2.5.4. Recent Developments and Future Outlook
5.2.6. ChemDiv
5.2.6.1. Company Overview
5.2.6.2. Service Portfolio
5.2.6.3. Recent Developments and Future Outlook
5.2.7. Covance
5.2.7.1. Company Overview
5.2.7.2. Financial Information
5.2.7.3. Service Portfolio
5.2.7.4. Recent Developments and Future Outlook
5.2.8. Medpace
5.2.8.1. Company Overview
5.2.8.2. Financial Information
5.2.8.3. Service Portfolio
5.2.8.4. Recent Developments and Future Outlook
5.2.9. QPS
5.2.9.1. Company Overview
5.2.9.2. Service Portfolio
5.2.9.3. Recent Developments and Future Outlook
5.3. Pharmaceutical Contract Research Service Providers in Europe
5.3.1. Concept Life Sciences
5.3.1.1. Company Overview
5.3.1.2. Service Portfolio
5.3.1.3. Recent Developments and Future Outlook
5.3.2. Evotec
5.3.2.1. Company Overview
5.3.2.2. Financial Information
5.3.2.3. Service Portfolio
5.3.2.4. Recent Developments and Future Outlook
5.4. Pharmaceutical Contract Research Service Providers in Asia-Pacific
5.4.1. ChemPartner
5.4.1.1. Company Overview
5.4.1.2. Financial Information
5.4.1.3. Service Portfolio
5.4.1.4. Recent Developments and Future Outlook
5.4.2. Pharmaron
5.4.2.1. Company Overview
5.4.2.2. Service Portfolio
5.4.2.3. Recent Developments and Future Outlook
5.4.3. Syngene
5.4.3.1. Company Overview
5.4.3.2. Financial Information
5.4.3.3. Service Portfolio
5.4.3.4. Recent Developments and Future Outlook
5.4.4. Torrent Pharma
5.4.4.1. Company Overview
5.4.4.2. Financial Information
5.4.4.3. Service Portfolio
5.4.4.4. Recent Developments and Future Outlook
5.4.5. WuXi AppTec
5.4.5.1. Company Overview
5.4.5.2. Financial Information
5.4.5.3. Service Portfolio
5.4.5.4. Recent Developments and Future Outlook

6. COMPANY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Methodology
6.3. Key Parameters
6.4. Company Competitiveness Analysis: Pharmaceutical Contract Research Service Providers
6.4.1. Pharmaceutical Contract Research Service Providers based in North America
6.4.2. Pharmaceutical Contract Research Service Providers based in Europe
6.4.3. Pharmaceutical Contract Research Service Providers based in Asia- Pacific and Rest of the World

7. PARTNERSHIPS AND COLLABORATIONS
7.1. Chapter Overview
7.2. Partnership Models
7.3. Pharmaceutical Contract Research Service Providers: List of Partnerships and Collaborations
7.3.1. Analysis by Year of Partnership
7.3.2. Analysis by Type of Partnership
7.3.3. Analysis by Scale of Operation
7.3.4. Analysis by Target Therapeutic Area
7.3.5. Analysis by Year of Partnership and Type of Partner
7.3.6. Analysis by Type of Partnership and Type of Partner
7.3.7. Most Active Players: Analysis by Number of Partnerships
7.3.8. Regional Analysis
7.3.8.1. Intercontinental and Intracontinental Agreements

8. MERGERS AND ACQUISITIONS
8.1. Chapter Overview
8.2. Merger and Acquisition Models
8.3. Pharmaceutical Contract Research Service Providers: Mergers and Acquisitions
8.3.1. Analysis by Year of Acquisition
8.3.2. Analysis by Geography
8.3.3. Intercontinental and Intracontinental Deals
8.4. Analysis by Key Value Drivers
8.4.1. Mergers and Acquisitions: Analysis by Key Value Drivers
8.5. Valuation Analysis: Acquisition Deal Multiples
8.5.1. Prominent Acquirers: Analysis by Number of Acquisitions

9. MARKET FORECAST AND OPPORTUNITY ANALYSIS
9.1. Chapter Overview
9.2. Forecast Methodology and Key Assumptions
9.3. Global Pharmaceutical Contract Research Service Providers Market, 2021-2030
9.4. Global Pharmaceutical Contract Research Service Providers Market, 2021-2030: Distribution by Scale of Operation
9.4.1. Global Pharmaceutical Contract Research Service Providers Market for Discovery Services, 2021-2030
9.4.2. Global Pharmaceutical Contract Research Service Providers Market for Preclinical Services, 2021-2030
9.4.3. Global Pharmaceutical Contract Research Service Providers Market for Clinical Services, 2021-2030
9.5. Global Pharmaceutical Contract Research Service Providers Market, 2021-2030: Distribution by Target Therapeutic Area
9.5.1. Global Pharmaceutical Contract Research Service Providers Market for Oncological Disorders, 2021-2030
9.5.2. Global Pharmaceutical Contract Research Service Providers Market for Infectious Diseases, 2021-2030
9.5.3. Global Pharmaceutical Contract Research Service Providers Market for Neurological Disorders, 2021-2030
9.5.4. Global Pharmaceutical Contract Research Service Providers Market for Inflammatory Disorders, 2021-2030
9.5.5. Global Pharmaceutical Contract Research Service Providers Market for Cardiovascular Disorders, 2021-2030
9.5.6. Global Pharmaceutical Contract Research Service Providers Market for Dermatological Disorders, 2021-2030
9.5.7. Global Pharmaceutical Contract Research Service Providers Market for Ophthalmological Diseases, 2021-2030
9.5.8. Global Pharmaceutical Contract Research Service Providers Market for Respiratory Disorders, 2021-2030
9.5.9. Global Pharmaceutical Contract Research Service Providers Market for Other Disorders, 2021-2030
9.6. Global Pharmaceutical Contract Research Service Providers Market, 2021-2030: Distribution by Region
9.6.1. Pharmaceutical Contract Research Service Providers Market in North America, 2021-2030
9.6.2. Pharmaceutical Contract Research Service Providers Market in Europe, 2021-2030
9.6.3. Pharmaceutical Contract Research Service Providers Market in Asia-Pacific, 2021-2030
9.6.4. Pharmaceutical Contract Research Service Providers Market in Middle East, 2021-2030
9.6.5. Pharmaceutical Contract Research Service Providers Market in Latin America, 2021-2030

10. TOTAL COST OF OWNERSHIP IN PHARMACEUTICAL CONTRACT RESEARCH ORGANIZATION
10.1. Chapter Overview
10.2. Key Assumptions and Methodology
10.3. Output

11. CASE STUDY: BIOPHARMACEUTICAL CONTRACT RESEARCH SERVICES MARKET
11.1. Chapter Overview
11.2. Biopharmaceutical CROs: Overall Market Landscape
11.2.1. Analysis by Year of Establishment, Company Size and Location of Headquarters
11.2.2. Analysis by Scale of Operation
11.3. Preclinical Biopharmaceutical CROs
11.3.1. Analysis by Year of Establishment
11.3.2. Analysis by Company Size
11.3.3. Analysis by Location of Headquarters
11.3.4. Analysis by Type of Biologic
11.3.5. Analysis by Type of Services Offered
11.4. Clinical Biopharmaceutical CROs
11.4.1. Analysis by Year of Establishment
11.4.2. Analysis by Company Size
11.4.3. Analysis by Location of Headquarters
11.4.4. Analysis by Type of Biologics
11.4.5. Analysis by Type of Services Offered

12. EXECUTIVE INSIGHTS
12.1. Chapter Overview
12.2. ChemoGenics Biopharma
12.2.1. Company Snapshot
12.2.2. Interview Transcript: Francis X. Tavares, Founder and Chief Executive Officer

13. CONCLUDING REMARKS14. APPENDIX 1: TABULATED DATA

Companies Mentioned

  • 2bind
  • 4Clinics
  • A+ Science
  • A10 Clinical Solutions
  • A2 Healthcare
  • Aaranya Biosciences
  • AbClon 
  • Absolute Research Solutions
  • Absorption Systems
  • Accelera
  • Accelero Biostructures
  • Accell Clinical Research
  • Accelsiors
  • Accre Chemicals
  • Accuprec Research Labs
  • Accutest Research Laboratories
  • ACD/Labs
  • ACEA Biosciences
  • ACI Clinical
  • Aclaris Therapeutics
  • ACLIRES International
  • ACM Global Laboratories
  • aCROnordic 
  • ACROVAN
  • Actimus Bio
  • Activa Cro
  • Addex Therapeutics
  • Adesis
  • Advanced Clinical
  • Advanced Drug and Device Services (ADDS)
  • Aepodia
  • African Clinical Research Organization (ACRO) 
  • Agilent
  • AGINKO Research
  • Agno Pharma
  • AiPing Pharmaceutical
  • AIT Bioscience
  • Aix Scientifics
  • Aizant Drug Research Solutions
  • Akcelis
  • Albuquerque Clinical Trials
  • Alcami
  • Alimentiv
  • Alira Health
  • Alliance Pharma
  • Allphase Clinical Research
  • Almac
  • Almirall
  • Alpha Bioresearch
  • Alpha Genesis (AGI)
  • Altasciences
  • Althian- Clinical Research Management Center
  • Altiora
  • Alturas Analytics
  • Amarex Clinical Research
  • AmbioPharma
  • Amedes
  • American Preclinical Services
  • AML Clinical Services
  • AMRI
  • Anabase International
  • Analgesic Solutions
  • Anapharm Bioanalytics
  • Anavo Therapeutics
  • ANI Pharmaceuticals
  • Anova Enterprises
  • AnSys Laboratories
  • ANTAEA
  • Antev
  • APCER Life Sciences
  • APEIRON Biologics
  • A-Pharma
  • Appletree CI Group
  • Applied Healthcare Resource Management (AHRM)
  • APRO
  • ARCHIMEDlife
  • Arcinova
  • Argint International Clinical Research and Development Services (Argint)
  • Aris Pharmaceuticals
  • Array Biostatistics (Acquired by CATO SMS)
  • Asclepia Medchem Solutions
  • Asia Global Research (AGR)
  • Asiatic Clinical Research
  • ASINEX
  • ASSAY Clinical Research
  • Assay.Works
  • Astron Research
  • AstronauTx
  • Atlant Clinical
  • Atuka
  • August Bioservices
  • Auriga Research
  • Aurigene Pharmaceutical Services
  • Aurora Fine Chemicals
  • Aurum Clinical Research (ACR)
  • Avance Clinical (formerly CPR Pharma Services)
  • Averica Discovery 
  • Avistron Chemistry Services
  • Avitacor
  • AVVA Pharmaceuticals
  • AXIS Clinicals
  • Axon Clinical Research
  • Axon Medchem
  • Axxam
  • Azidus
  • BalticCRO
  • Biomedical Advanced Research and Development Authority (BARDA)
  • BASF
  • Baxter
  • Bayer
  • BBK Worldwide
  • BePharBel Manufacturing
  • Bienta (a part of Enamine Biology Services)
  • BioAge Labs
  • Bioanalytical Laboratory Services (BLS)
  • BioAscent
  • BioBlocks
  • Bioclinica
  • BioDuro
  • Biogen
  • Biognos
  • BIOMAPAS CODE OF ETHICS
  • Biomere
  • Bioneeds
  • Bionicsgene
  • BioNTech
  • BioPharma Services
  • BioPredict
  • Biorasi Clinical Research
  • BioReliance
  • bioskin
  • BioSolveIT
  • Biospective
  • BioStat International
  • BioTek Instruments (part of Agilent Technologies)
  • Biotoxtech
  • Biotrial
  • Biotrofix
  • Biovantix
  • BioVectra
  • BlueClinical
  • Blueprint Genetics
  • BOC Sciences
  • Boston MedTech Advisors
  • BPI Service (subsidiary of Federal Association of the Pharmaceutical Industry)
  • BRI Biopharmaceutical Research
  • BTS Research
  • Buffalo Institute for Genomics and Data Analytics (BIG)
  • C&R Research
  • C.RIS Pharma
  • Calmark 
  • Cambrex Zenara (formerly known as Zenara Pharma)
  • Cambridge Regulatory Services
  • Carna Biosciences
  • Cascade Chemistry
  • Casma Therapeutics
  • Catalent Pharma
  • Catalyst Clinical Services
  • CATO SMS
  • CCDRD 
  • CCS Associates (CCSA)
  • CD BioSciences
  • Cedilla Therapeutics
  • Celerion
  • Center for Pharmacology and Analysis (CEPHA)
  • Cerbios-Pharma
  • Certara
  • Certus International
  • Charles River Laboratories
  • CHDI Foundation
  • Checkpoint Therapeutics 
  • ChemAxon
  • ChemBio Discovery Solutions
  • ChemBridge
  • ChemDiv
  • ChemModeling
  • ChemoGenics BioPharma
  • Chemotargets
  • ChemPartner
  • Chongqing Huapont Pharmaceutical
  • CIRION
  • Cliantha Research
  • ClinAudits
  • ClinBAY
  • ClinChoice
  • ClinDatrix
  • Clinfinity
  • Clinical Research Consulting
  • Clinical Service Center (CSC)
  • Clinical Trial Service (CTS)
  • ClinicalConnection
  • Clinilabs
  • Clinipace
  • CliniRx
  • CLINTRIA
  • Clinitude
  • Clinlogix
  • ClinMax
  • Clinres Farmacija
  • ClinServ
  • ClinSmart
  • ClinSoft
  • Clinstat Consulting
  • Clintec
  • CluePoints
  • CMIC Holdings
  • CNS Contract Research
  • CNS Pharmaceuticals
  • Cohortias
  • Colorado Computational
  • Comac Medical
  • ComInnex
  • Commonwealth Biotechnologies
  • Comparative Biosciences
  • Concentrics Research
  • Concept Life Sciences
  • Confluence Discovery Technologies
  • Confo Therapeutics
  • Congenix
  • Conifer Point Consulting
  • Contract Pharmaceuticals
  • Convex CRO
  • CordenPharma
  • CordenPharma
  • CoreRx
  • Corlexia Clinical Services
  • CORONIS Research
  • Covance
  • CreaGen
  • Creative Biostructure
  • Credevo
  • Crelux
  • Cresset
  • Criterium
  • CRM-CRO
  • Crocus Medical
  • Cromos Pharma
  • CROPRIME
  • Crown CRO
  • CTI
  • CW Research & Management
  • CytoAgents
  • Cytovation
  • Dabur Research Foundation (DRF)
  • Dalriada Drug Discovery
  • Dalton Pharma Services
  • Datapharm 
  • DaVinci Biomedical Research Products
  • DaVita Clinical Research
  • Deshpande Laboratories
  • dicentra
  • Dimension Research
  • Direct Biologics
  • DIVERCHIM
  • Divi's Laboratories
  • Dizal Pharmaceutical
  • dMed Biopharmaceutical
  • DMPK4Biotech
  • Domainex
  • Dorian Therapeutics
  • Double Bond Pharmaceutical
  • DP Clinical
  • DPT Laboratories
  • Drik
  • DRK Pharma Solutions
  • DSK InnoSciences
  • DSP Clinical Research
  • DyNAbind
  • DZS Clinical Services
  • EDASA Scientific
  • Edelris
  • EGCP
  • EGeen
  • Emerson
  • Emery Pharma
  • EMINent Services 
  • Emissary International
  • Enamine
  • Epirium Bio
  • Equinox Pharma
  • Ergomed
  • ERT
  • ESTERN Medical CRO 
  • ethica CRO
  • Eurofins Discovery
  • Everest Clinical Research
  • Evonik
  • Evotec
  • ExCellThera
  • Excelya
  • Experimentica
  • Explora BioLabs
  • Farmigea
  • Farzan Clinical Research
  • FGK Clinical Research
  • First Clinical Research
  • Flamma
  • Forma Therapeutics
  • Frontage Laboratories
  • Galapagos 
  • Gavi
  • GB Pharma
  • Gedeon Richter
  • Gencore BioPharma
  • Genentech
  • Genesis Drug Discovery & Development
  • Genetron Holdings
  • Genpro Research
  • George Clinical
  • GI Innovation
  • GI Reviewers
  • Gilead Sciences
  • Global Center for Medical Innovation (GCMI)
  • GMP Bio
  • Gotham Therapeutics
  • GP Pharm
  • Grayline Research Center
  • Green Cross Lab Cell
  • GRK Research Laboratories
  • GVK Biosciences
  • H&J CRO International
  • Hamamatsu Pharma Research (HPR)
  • Harvis Pharm
  • Health Decisions
  • HealthCare Global Enterprises
  • Highlight Therapeutics
  • Hikma Pharmaceuticals
  • Hippocrates Research (HR)
  • HitGen
  • Holburn Biomedical
  • Hoth Therapeutics
  • HungaroTrial
  • Hurley Consulting Associates
  • Hyperion Biotechnology
  • ICON
  • International Drug Development Institute (IDDI)
  • IIT Delhi
  • IKCON PHARMA
  • Immunocure Discovery Solutions
  • Imperial Clinical Research Services
  • Imperial College London
  • ImQuest BioSciences
  • InCROM
  • Indivirtus
  • Info Kinetics
  • InformedDNA
  • IniXium
  • Innovative Informatica Technologies
  • Inotiv
  • Inoviem
  • Inspire
  • Integral Biosciences
  • Integrium
  • InteRNA Technologies
  • International Clinical Trials Association
  • International HealthCare (IHC) 
  • Intonation Research Laboratories
  • Intrials Clinical Research
  • Invivoscribe 
  • IonsGate Preclincal Services 
  • IPS Therapeutique (IPST)
  • IQVIA
  • IRBM
  • Iris Pharma
  • IRW
  • Isochem
  • JANIX
  • Janssen Biotech
  • Jehangir Clinical Development Centre (JCDC)
  • JOANNEUM RESEARCH
  • JRF Global
  • JSS Medical Research
  • Jubilant Biosys
  • Julius Clinical
  • Kalexsyn
  • KCAS Bioanalytical and Biomarker Services
  • KCR
  • Key Organics
  • Klinar
  • KMR Group
  • KP Pharmaceutical Technology
  • KPS Clinical Services
  • Kriger Research International
  • Kymera
  • Lambda Therapeutics Research 
  • Lancaster University
  • Laurus Synthesis
  • LAVA Therapeutics
  • LAXAI Life Sciences (a subsidiary of Laxai Pharma)
  • LegoChem Biosciences (LCB)
  • Leon Research
  • LG Chem
  • Liatris Biosciences
  • Life Chemicals
  • Linical
  • LINK Medical
  • Lipigon
  • Liverpool ChiroChem
  • Lonza
  • Lotus Clinical Research
  • Lotus Pharmaceuticals
  • LSK Global Pharma Services
  • Lubrizol Life Science (LLS Health)
  • Lucid Diagnostics
  • MakroCare
  • Marksman Healthcare
  • Mascot Industries
  • MB Quest
  • Medelis
  • Medfiles
  • Medi Service
  • Medical Data Analytics (MDA)
  • Medicilon
  • Medicines Evaluation Unit (MEU) 
  • Medidata Solutions
  • Mediolanum Cardio Research (MCR)
  • Mediprobe Research
  • Medis Research Group
  • Medpace
  • MedPharm
  • MedReleaf
  • MedTrials
  • MENADIONA
  • MENE Health Group (MHG)
  • Merck & Co.
  • Meruvax Pharma
  • Metrics Champion Consortium (MCC)
  • Metrics Contract Services
  • Metrics Research
  • Micar Innovation
  • Micro Therapeutic Research Labs (MTRL)
  • MicroConstants
  • Micro-Sphere
  • Mitsubishi Tanabe Pharma
  • MLM Medical Labs
  • MMS Holdings
  • Molcan
  • Molecular Cornerstones
  • Molecular Forecaster
  • Molecule CRO
  • Molsoft
  • Moncoa Medical Research
  • Monipol
  • Monitioring Force
  • MonitorCRO
  • Morley Research Consortium
  • Morphic
  • MRI Global
  • MSN Laboratories
  • MTZ Clinical Research
  • My Green Lab
  • Nagy Research
  • Nanjing Pharmatechs
  • Nanosyn
  • Nanyang Technological University (NTU)
  • National Cancer Institute
  • NCGS
  • Neurofit
  • Neurosolutions
  • New England Discovery Partners (NEDP)
  • Next Pharma
  • Nextar Chempharma Solutions
  • NexusPharma
  • NIAID
  • Nitza Bioventure
  • NMX Research and Solutions
  • Noble Life Sciences
  • NorthEast BioLab
  • NorthWise Services
  • Norwich Clinical Research Associates
  • Nostrum Biodiscovery
  • NovaData Solutions
  • NovAlix
  • NovaMechanics
  • Novotech
  • NTZ Lab
  • NuChem Therapeutics
  • Nutrasource
  • Nuvisan Pharma
  • OCT Clinical
  • OMass Therapeutics
  • Oncodesign
  • Oncology Ventures
  • ONCOtherapeutics
  • Onq Research
  • OpenEye Scientific
  • Open Orphan
  • Operatrix Consulting
  • OPN Healthcare
  • Ora Clinical
  • Orbis Clinical
  • Organo Chem
  • Oroxcell
  • Orphan Reach
  • Osong
  • OTAVA Chemicals
  • P3 Research
  • Pacific BioLabs
  • Pacific Bridge Medical
  • Palm Beach CRO
  • Palobiofarma
  • Paraxel
  • Paraza Pharma
  • Patheon by Thermo Fischer Scientific
  • Peachtree BioResearch Solutions
  • PELVIPHARM
  • ProXyChem
  • Pfizer CentreOne®
  • Pharma Inventor
  • Pharma Medica Research
  • Pharmacelera
  • Pharmaceuticals Product Development
  • Pharmaffiliates
  • Pharmahungary
  • PharmAI
  • Pharmalys
  • PharmaResources
  • Pharmaron
  • PharmaSeek (acquired by WCG)
  • Pharmatest Services
  • Pharm-Olam
  • PharmStats
  • PharSafer®
  • PHASTAR
  • PHDS Healthcare Research
  • Phoneix Clinical Research
  • Physiogenex
  • Pierrel SpA
  • pilot Mainz 
  • Pion
  • Piramal Pharma Solutions
  • Pivotal
  • POPSI CUBE
  • Porton Fine Chemicals
  • PPC Group
  • PRA Health Sciences
  • Premier Research
  • Prestwick Chemical
  • Princeton BioMolecular Research
  • Procaps
  • ProDERM
  • Profacgen
  • Profil
  • Proinnovera
  • Promedica International
  • PROMETRIKA
  • ProRelix Research
  • Prosarix 
  • Proswell Medical
  • Proteros Fragments
  • ProtoQSAR
  • Provid Pharmaceuticals
  • Providence Clinical Research
  • Proxima
  • Proximagen
  • ProXyChem
  • ProZyme
  • Prudentia Group
  • PSI
  • Pyramid Laboratories
  • Pyxis Discovery
  • QPS
  • Q-Trials
  • Quality Assistance
  • Quality Chemical Laboratories
  • Quanticate
  • Quartesian
  • Quay Pharmaceuticals
  • Quotient Sciences
  • Raptim Research
  • RASA Lifescience Informatics
  • Raybow Pharmaceuticals
  • Reaction Biology
  • Reaxense
  • Recipharm
  • Red Glead Discovery
  • Redox Scientific
  • Redoxis
  • Reliance Life Sciences
  • Research Assist
  • Resolution Bioscience
  • Resolution Latin America
  • Rho
  • Richmond Pharmacology 
  • Rottendorf Pharma
  • RTI Health Solutions
  • RTI International
  • Sacura
  • Sai Life Sciences
  • Sambi Pharma
  • Sandexis Molecular Design
  • Sanjeevani Bio
  • Sanofi
  • Sarah Cannon Development Innovations
  • SARomics Biostructures
  • Scandinavian CRO
  • Schiff & Company
  • SchinoPharm
  • Scian services
  • Scientific Bio-minds
  • Scimega
  • SchinoPharm
  • Scope International
  • Sekisui Xenotech
  • Selvita
  • SGS Life Sciences
  • SGS Life Sciences
  • Shamrock Structures
  • Siegfried
  • SilcsBio
  • SILLAR CLINICAL 
  • Simbec-Orion
  • Simulations Plus
  • Sinclair Research
  • Sipra Labs
  • SiREEN
  • Sitryx Therapeutics
  • SLG
  • SLR Biosciences
  • Smerud Medical Research Group
  • Smerud Medical Research International
  • SMO India
  • SNBL Japan
  • SoBran Bioscience
  • SOCAR Research
  • SofPromed
  • Solvias
  • SomaLogic
  • Sovereign Pharmaceuticals
  • Spaulding Clinical
  • Spectrum Clinical Research
  • Sphaera Pharma
  • SpiroChem
  • SPRI Ukraine
  • Squarepoint-Pointcare
  • Staidson
  • Standard Medical Products
  • Statistics Collaborative
  • STATKING Clinical Services
  • Stiris Research
  • Strain Chem
  • Strand Life Sciences
  • Strategic Regulatory Consulting
  • Structure Based Design
  • Sugen Life Sciences
  • Sun Pharma Advanced Research Company
  • Sundia
  • Sundia MediTech
  • SuperLab
  • Swiss Pharma
  • Sygnature Discovery
  • Symbio Research
  • Symeres
  • Symphony Pharma Life Science
  • Synapse
  • Synchron 
  • Syneos Health
  • Synergy Research Group
  • Syngene
  • SynphaTec Japon
  • SYNSIGHT
  • Synteract
  • SYNthesis med chem
  • Syreon Clinical Research
  • Sysdata Consulting
  • T3D Therapeutics
  • Takeda Pharmaceutical
  • Target Health
  • Taros Chemicals
  • TCA Clinical Research
  • TCG Lifesciences
  • Tech Observer
  • TFS HealthScience
  • The Alliance for Clinical Trials in Oncology
  • The Avoca Group
  • The Kitasato Institute
  • The Micron Group
  • The Siesta Group
  • The SIRO Clinpharm
  • Theradex Oncology
  • TheraIndx Lifesciences
  • Therapeutics
  • Tigermed
  • TimTec
  • Titan Pharma
  • TKL Research
  • TMG Research
  • Tolmar
  • Tonus-Les
  • Torrent Pharm
  • Toxikon 
  • TransPharm Preclinical Solutions
  • Trennic Data Services
  • Trifecta Clinical
  • Tubilux Pharma (acquired by C.O.C Farmaceutici)
  • ULTRA Scientific
  • Ultratech India
  • Unichem Laboratories
  • Unimark Remedies
  • Unison
  • University of Edinburgh
  • University of Manchester
  • University of Sheffield 
  • UPM Pharmaceuticals
  • UPPTHERA
  • US Pharma Lab
  • USV
  • Vagdevi InnoScience
  • Veeda CRO
  • Velesco Pharmaceutical Services
  • Velos
  • Vergo Pharma Research
  • Veristat
  • Vernalis
  • Verum Clinical Research
  • Vimta Labs
  • Vipergen
  • Vipragen Biosciences
  • Viva Biotech
  • Vlife Sciences
  • Vyome Therapeutics
  • Waife & Associates
  • WellSpring Consumer Healthcare
  • Westat 
  • Wilmington PharmaTech
  • Windlas
  • Windlas Healthcare
  • Winicker Norimed
  • WCG IRB 
  • Wisdom Pharmaceuticals
  • Worldwide Clinical Trials
  • WuXi AppTec
  • XoNovo
  • Xpose Therapeutics
  • Xtal BioStructures
  • Yaadvi Scientific Solutions
  • Yale University
  • Yao Pharma
  • Young In Scientific
  • Yung Zip Chemical
  • Zaggo
  • Zambon
  • ZEINCRO
  • Zenith Healthcare
  • Zenobia Fragments
  • ZenRise
  • Apeloa Pharma
  • Zhejiang Langhua Pharmaceutical
  • ZM Company
  • ZoBio
  • Zydus BSV Pharma

Methodology

 

 

Loading
LOADING...

Related Topics

Related Reports

Contract Research Outsourcing - Global Strategic Business Report - Product Image

Contract Research Outsourcing - Global Strategic Business Report

  • Report
  • 453 Pages
  • Global
From
Contract Research Organisations (CROs) Market Report 2023-2033 - Product Image

Contract Research Organisations (CROs) Market Report 2023-2033

  • Report
  • 353 Pages
  • Global
From
Contract Research Organization Services Market Forecasts from 2023 to 2028 - Product Image

Contract Research Organization Services Market Forecasts from 2023 to 2028

  • Report
  • 140 Pages
  • Global
From
Global Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Forecast 2024-2030 - Product Image

Global Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Contract Research Organization (CRO) Services Market: Trends, Opportunities and Competitive Analysis 2023-2028 - Product Image

Contract Research Organization (CRO) Services Market: Trends, Opportunities and Competitive Analysis 2023-2028

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.